Comparison of revised EWGSOP2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass.

Calf circumference (CC) has been established as a marker of muscle mass (MM) with good performance for predicting survival in individuals with cancer. The study aims to determine the prevalence of sarcopenia according to the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) criteria a...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ana Paula Trussardi Fayh, Iasmin Matias de Sousa
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/0beb42d4199049abb571cf8ccbfd9435
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0beb42d4199049abb571cf8ccbfd9435
record_format	dspace
spelling	oai:doaj.org-article:0beb42d4199049abb571cf8ccbfd94352021-12-02T20:06:17ZComparison of revised EWGSOP2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass.1932-620310.1371/journal.pone.0257446https://doaj.org/article/0beb42d4199049abb571cf8ccbfd94352021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0257446https://doaj.org/toc/1932-6203Calf circumference (CC) has been established as a marker of muscle mass (MM) with good performance for predicting survival in individuals with cancer. The study aims to determine the prevalence of sarcopenia according to the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) criteria and to evaluate the accuracy of sarcopenia using low CC relative to MM assessment by computed tomography (CT) at third lumbar vertebra level (L3) as a reference. Cross-sectional study with cancer patients aged ≥ 60 years. Data included socio-demographic, clinical and anthropometric variables. MM was assessed by CC and by CT images at the L3. Sarcopenia was diagnosed according to the EWGSOP2 criteria: a) low handgrip strength (HGS) + reduced MM evaluated by CT; and b) low HGS + low CC. Pearson's correlation, accuracy, sensitivity, specificity, positive predictive and negative predictive value were analyzed. A total of 108 patients were evaluated, age of 70.6 ± 7.4 years (mean ± standard deviation). The prevalence of sarcopenia was of 24.1% (low MM) and 25.9% (low CC). The Kappa test showed a substantial agreement (K = 0.704), 81% sensitivity, and 92% specificity. Although the EWGSOP2 advises that we should use CC measures in the algorithm for sarcopenia when no other MM diagnostic methods are available, the findings allow the use of CC instead of MM by CT in cancer patients.Ana Paula Trussardi FayhIasmin Matias de SousaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 9, p e0257446 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Ana Paula Trussardi Fayh Iasmin Matias de Sousa Comparison of revised EWGSOP2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass.
description	Calf circumference (CC) has been established as a marker of muscle mass (MM) with good performance for predicting survival in individuals with cancer. The study aims to determine the prevalence of sarcopenia according to the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) criteria and to evaluate the accuracy of sarcopenia using low CC relative to MM assessment by computed tomography (CT) at third lumbar vertebra level (L3) as a reference. Cross-sectional study with cancer patients aged ≥ 60 years. Data included socio-demographic, clinical and anthropometric variables. MM was assessed by CC and by CT images at the L3. Sarcopenia was diagnosed according to the EWGSOP2 criteria: a) low handgrip strength (HGS) + reduced MM evaluated by CT; and b) low HGS + low CC. Pearson's correlation, accuracy, sensitivity, specificity, positive predictive and negative predictive value were analyzed. A total of 108 patients were evaluated, age of 70.6 ± 7.4 years (mean ± standard deviation). The prevalence of sarcopenia was of 24.1% (low MM) and 25.9% (low CC). The Kappa test showed a substantial agreement (K = 0.704), 81% sensitivity, and 92% specificity. Although the EWGSOP2 advises that we should use CC measures in the algorithm for sarcopenia when no other MM diagnostic methods are available, the findings allow the use of CC instead of MM by CT in cancer patients.
format	article
author	Ana Paula Trussardi Fayh Iasmin Matias de Sousa
author_facet	Ana Paula Trussardi Fayh Iasmin Matias de Sousa
author_sort	Ana Paula Trussardi Fayh
title	Comparison of revised EWGSOP2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass.
title_short	Comparison of revised EWGSOP2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass.
title_full	Comparison of revised EWGSOP2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass.
title_fullStr	Comparison of revised EWGSOP2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass.
title_full_unstemmed	Comparison of revised EWGSOP2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass.
title_sort	comparison of revised ewgsop2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass.
publisher	Public Library of Science (PLoS)
publishDate	2021
url	https://doaj.org/article/0beb42d4199049abb571cf8ccbfd9435
work_keys_str_mv	AT anapaulatrussardifayh comparisonofrevisedewgsop2criteriaofsarcopeniainpatientswithcancerusingdifferentparametersofmusclemass AT iasminmatiasdesousa comparisonofrevisedewgsop2criteriaofsarcopeniainpatientswithcancerusingdifferentparametersofmusclemass
_version_	1718375344474423296

Comparison of revised EWGSOP2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass.

Ejemplares similares